Celgene Corp. to pay $280M to settle cancer drug fraud suit
ABC News: Health
A New Jersey pharmaceutical company has agreed to pay $280 million to settle a federal whistleblower lawsuit alleging it committed fraud promoting two drugs for unapproved cancer treatments
No comments:
Post a Comment